How do we know whether an invention disclosure is worth pursuing?
Our Invention Disclosure Assessment helps triage early-stage opportunities by identifying those with the strongest technical, commercial and IP potential, so TTO teams can prioritise where time, budget and patent filing costs are most likely to generate return.
We are looking to license IP to a third party. What underpins a royalty opinion?
A supportable royalty opinion needs more than database evidence. We consider the legal strength of the IP, technical contribution, commercial context, comparable transactions and deal structure.
We need help assessing whether a licence offer is commercially reasonable. Can you assist?
Yes. We review proposed licence terms through a commercial and valuation lens, helping you understand whether the economics, structure and risk allocation are aligned. This can be particularly helpful where there is pressure to move quickly or limited internal benchmarking available.
Can you help us estimate the value of a university technology or patent portfolio?
Yes. We provide valuation advice across individual assets, patent families, know-how, platform technologies and broader commercialisation portfolios, supporting licensing, spinout formation, internal decision-making, financial reporting, disputes or transactions.
We are forming a spinout. Can you help with the valuation issues?
Yes. We help assess the value of contributed IP and understand how that value interacts with equity allocation, licence terms and broader deal structuring, so the commercial position is credible, well supported and easier to explain to founders, investors and stakeholders.
We are negotiating with an industry partner. Can you support us even if legal counsel is already involved?
Yes. Our role is complementary to legal advice. While lawyers focus on legal risk and drafting, we focus on value, economics, market context and commercial structure. Together, these perspectives typically produce better negotiation outcomes than either discipline working alone.
Can you benchmark licensing terms even when there are no perfect comparable deals?
Yes. For many new or early-stage technologies, direct comparables are limited. We use a structured approach that considers relevant licensing data, industry norms, economic logic and the specific features of the technology, market and transaction to reach a well-supported commercial range.
Can you help us explain the commercial potential of a technology to internal stakeholders?
Yes. We turn technical detail into a commercial story a board or committee can act on.
Can you audit our IP portfolio to identify risk and value opportunities?
Yes. Our IP audit helps research organisations understand where value is well protected, where risk may be sitting, and where there are opportunities to strengthen commercial outcomes, including ownership, protection strategy, contractual position, portfolio concentration and commercial alignment.
We have a limited budget. How can you structure engagements to manage this?
We structure engagements in modular stages, allowing scope and cost to scale with your needs. An initial review of comparable licensing transactions may be sufficient to support early discussions; if the opportunity progresses, we can then undertake a more detailed royalty-rate opinion.
